Attitudes and beliefs toward lung cancer screening among US Veterans.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE
    • Publication Information:
      Publication: 2016- : New York : Elsevier
      Original Publication: Chicago : American College of Chest Physicians
    • Subject Terms:
    • Abstract:
      Background: Lung cancer (LC) is the leading cause of cancer-related death for veterans cared for by the US Veterans Health Administration. The LC burden among veterans is almost double that of the general population. Before implementation of an LC screening program, we set out to assess the role of beliefs and attitudes toward LC screening among veterans.
      Methods: Veterans presenting to the Ralph H. Johnson VA Medical Center were invited to complete a self-administered survey. The survey comprised questions about demographics, smoking status, health status, and knowledge about LC and willingness to be screened. Responses from veteran ever and never smokers were compared.
      Results: A total of 209 veterans completed the survey. Smokers were significantly (P < .05) more likely than never smokers to be less educated, have a lower income, and report poorer health. Smokers were more likely than never smokers to have two or more comorbidities, which trended toward significance (P = .062). Smokers were more likely to have been told by a physician that they were at high risk for LC and to believe that they were at risk. Nearly all veterans surveyed (92.8%) would have a CT scan for LC screening, and 92.4% would have surgery for a screen-detected LC.
      Conclusions: Veterans are overwhelmingly willing to undergo screening for LC, and it seems that participation will not be a barrier to implementation of an LC screening program. The mortality benefit of LC screening, however, may not be generalizable to the veteran population because of a higher number of comorbid conditions.
    • Comments:
      Comment in: Chest. 2013 Dec;144(6):1749-50. (PMID: 24297116)
    • References:
      N Engl J Med. 2011 Aug 4;365(5):395-409. (PMID: 21714641)
      Cancer. 2005 Aug 15;104(4):833-40. (PMID: 15973670)
      J Natl Cancer Inst. 2010 Dec 1;102(23):1771-9. (PMID: 21119104)
      Cancer. 2012 Jul 1;118(13):3345-55. (PMID: 22072536)
      Cancer. 1989 Sep 1;64(5):1160-8. (PMID: 2758390)
      Thorax. 2007 Feb;62(2):126-30. (PMID: 17101739)
      Am J Prev Med. 1995 Jul-Aug;11(4):245-50. (PMID: 7495601)
      Mil Med. 2012 Jun;177(6):693-701. (PMID: 22730846)
      J Clin Oncol. 2012 May 1;30(13):1447-55. (PMID: 22454424)
      JAMA. 2004 Jan 7;291(1):71-8. (PMID: 14709578)
      Public Health Rep. 1997 May-Jun;112(3):212-7; discussion 218. (PMID: 9160055)
      Am J Epidemiol. 1993 Apr 1;137(7):787-96. (PMID: 8484370)
      Ann Intern Med. 2011 Oct 18;155(8):537-9. (PMID: 21893614)
      Lung Cancer. 2012 Sep;77(3):526-31. (PMID: 22681870)
      Ann Intern Med. 2003 Oct 7;139(7):558-63. (PMID: 14530226)
      JAMA. 2012 Jun 13;307(22):2418-29. (PMID: 22610500)
    • Grant Information:
      K24 DK093699 United States DK NIDDK NIH HHS; UL1 RR029882 United States RR NCRR NIH HHS
    • Publication Date:
      Date Created: 20130615 Date Completed: 20140313 Latest Revision: 20220321
    • Publication Date:
      20240829
    • Accession Number:
      PMC3848465
    • Accession Number:
      10.1378/chest.13-0056
    • Accession Number:
      23764896